News from all angles
(MedPage Today) -- A biochemical response to ursodeoxycholic acid (UDCA) at 12 months was associated with lower 5-year risks of hepatic decompensation and mortality in patients with primary biliary c…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network